Synthetic Biology - fact or fiction?
The panel featured industry peers Jim Lalonde from Inscripta, Zach Serber from Zymergen, and regulatory expert Martha ...
Cofounder, Zymergen
Search every verified Zach Serber interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Zach Serber, cofounder of Zymergen, has described synthetic biology as "unquestionably fact" while acknowledging that the field has been associated with hype and past failures. In a 2020 panel, he noted that Zymergen initially avoided the term "synthetic biology" because of its association with money-losing ventures, and said the company kept a low profile for years, only announcing its first product — a flexible polyamide film for consumer electronics — when it was already on the market. Serber has emphasized the importance of demonstrating results rather than making promises, and has argued that a strong profit motive is necessary to attract new entrants to the industry. In earlier talks from 2015 and 2016, Serber described Zymergen's approach as "radical empiricism," combining microbe engineering with software and automation to search for commercially useful genetic perturbations. He stated that the company was prototyping 360 novel biomolecules with DARPA support, focusing on materials with fast adoption cycles and low regulatory hurdles, such as adhesives and coatings. Serber has said that biology can provide a richer palette of chemicals than petroleum, and that Zymergen aims to make biology "the petroleum of the future" by producing superior materials, medicines, and agricultural products without reliance on fossil fuels.
The panel featured industry peers Jim Lalonde from Inscripta, Zach Serber from Zymergen, and regulatory expert Martha ...
Zach Serber, Co-founder and CSO of Zymergen, talked about how technology is being applied to unlock the power of biology to make sustainable products with inherently better properties to serve a wide range of industries and applications. Zach is devoted to finding alternatives to petroleum. He co-founded Zymergen to expand the impact and reach of industrial microbial fermentation. Zymergen applies radical new methods to design and improve microbes by rewriting their DNA. This capability allows the company to generate novel chemicals and advanced materials far faster, at lower costs, and with l…
Dr. Zach Serber, co-founder of Zymergen, explains his company's efforts to marry synthetic biology, machine learning and materials science to endow microbes with new genetic programs for creating impossible materials with novel and valuable properties. He spoke at DARPA's "Wait, What? A Future Technology Forum" on Sept. 9, 2015.
Zach Serber, Chief Science Officer and Vice President of Development at Zymergen, delivers a keynote address at DARPA’s "Biology Is Technology" symposium in New York City on June 23, 2015. The two-day event was held by DARPA's Biological Technologies Office to bring together leading-edge technologists, start-ups, industry, and academic researchers to look at how advances in engineering and information sciences can be used to drive biology for technological advantage.
Sign in to search the full transcript archive, filter by topic, and access every quote from Zach Serber.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans